Nailfold Capillaroscopic Changes in Psoriasis
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this observational study is to evaluate nailfold capillaroscopic changes in patients with psoriasis and to assess their correlation with disease severity. The study will also explore differences in capillaroscopic findings across different clinical types of psoriasis and skin phototypes (Fitzpatrick classification). The study will include patients diagnosed with psoriasis attending dermatology outpatient clinics. Participants will undergo clinical assessment and nailfold capillaroscopy to detect microvascular changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2026
CompletedFirst Posted
Study publicly available on registry
July 9, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 31, 2026
July 1, 2026
3 months
July 4, 2026
July 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Nailfold capillaroscopic abnormalities in psoriasis patients
Detection and description of nailfold capillaroscopic (NFC) abnormalities in patients with psoriasis.
Baseline
Secondary Outcomes (1)
Variation of nailfold capillaroscopic findings among different clinical types of psoriasis and correlation with disease severity (PASI score).
Baseline
Interventions
Participants will undergo nailfold capillaroscopy using a USB digital capillaroscope to assess microvascular changes in psoriatic patients. Clinical assessment including PASI score and evaluation of nail involvement will also be performed.
Eligibility Criteria
The study will include patients clinically diagnosed with psoriasis attending the dermatology outpatient clinics at Al-Hussein and Sayed Galal University Hospitals in Cairo, Egypt during the study period.
You may qualify if:
- Patients clinically diagnosed with psoriasis.
You may not qualify if:
- Patients with connective tissue diseases (e.g., systemic sclerosis, SLE)
- Diabetes mellitus or peripheral vascular disease
- Current smokers
- Pregnant or lactating women
- Recent use of vasodilators or beta-blockers
- Manual workers exposed to vibrating tools
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al-Hussein University Hospital & Sayed Galal University Hospital
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Dermatology & Venereology
Study Record Dates
First Submitted
July 4, 2026
First Posted
July 9, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 31, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share